Further, sales to laboratory supply distributors of our proprietary blood collection tubes, or BCTs, commenced during the three months ending June 30, 2018, which allow for the intact transport of liquid biopsy samples for research use only, or RUO, from regions around the world.Our revenue generating efforts are focused in three areas:•medical oncologists, surgical oncologists, pulmonologists, pathologists and other physicians who use the biomarker information we provide in order to determine the best treatment plan for their patients;•providing laboratory services utilizing both our CTC and ctDNA testing in order to help pharmaceutical and biopharmaceutical companies developing drug candidate therapies to treat cancer; and•licensing and/or selling our proprietary testing and/or technologies, including our BCTs, to partners in the United States and abroad.-2-Summary of the Rights OfferingSecurities to be OfferedWe are distributing to you, at no charge, one non-transferable Subscription Right to purchase one Unit for every share of our common stock(or share of common stock issuable upon exercise of our February 13, 2015, May 4, 2016, October 19, 2016, March 31, 2017, August 9, 2017 and January 30, 2018 warrants)that you owned on the Record Date.
We may redeem the Warrants for $                     per Warrant if our common stock closes above $                    per share for ten consecutive trading days, provided that we may not do so prior to the first anniversary of closing of the Rights Offering.Record Date5:00 p.m., Eastern Time,                     , 2018.Basic Subscription RightsYour Basic Subscription Right will entitle you to purchase one Unit at the Subscription Price.Over-Subscription PrivilegeIf you exercise your Basic Subscription Rights in full, you may also choose to purchase a portion of any Units that are not purchased by our other stockholders or warrant holders through the exercise of their Basic Subscription Rights, subject to proration and stock ownership limitations described elsewhere in this prospectus.Expiration DateThe Subscription Rights will expire at 5:00 p.m., Eastern Time, on                               , 2018.Procedure for Exercising Subscription RightsTo exercise your Subscription Rights, you must take the following steps:If you are a record holder of our common stock orwarrants issued February 13, 2015, May 4, 2016, October 19, 2016, March 31, 2017, August 9, 2017 and January 30, 2018as of the Record Date, you must deliver payment and a properly completed Rights Certificate to the Subscription Agent to be received before 5:00 p.m., Eastern Time,               on                              , 2018.
See “The Rights Offering-The Subscription Rights-Over-Subscription Privilege.” To the extent you properly exercise your Over-Subscription Privilege for an amount of Units that exceeds the number of unsubscribed Units available to you, any excess subscription payments will be returned to you within 10 business days after the expiration of the Rights Offering, without interest or deduction., our Subscription Agent for the Rights Offering, will determine the allocation of Over-Subscription Requests based on the formula described above.May the Subscription Rights that I exercise be reduced for any reason?Yes. While we are distributing to holders of our common stock and holders of our February 13, 2015, May 4, 2016, October 19, 2016, March 31, 2017, August 9, 2017 and January 30, 2018 warrants one Subscription Right for every share of common stock (including each share of common stock issuable upon exercise of warrants issued February 13, 2015, May 4, 2016, October 19, 2016, March 31, 2017, August 9, 2017 and January 30, 2018) owned on the Record Date, we are only seeking to raise $25.0 million dollars in gross proceeds in this Rights Offering.
See“Risk Factors”for discussion of some of the risks involved in investing in our securities.How do I exercise my Subscription Rights?If you are a stockholder or warrant holder of record (meaning you hold your shares of our common stock or participating warrants in your name and not through a broker, dealer, bank or other nominee) and you wish to participate in the Rights Offering, you must deliver a properly completed and signed Rights Certificate, together with payment of the Subscription Price for both your Basic Subscription Rights and any Over-Subscription Privilege you elect to exercise, to the Subscription Agent before 5:00 p.m., Eastern Time,   on                            , 2018.
You should not consider the Subscription Price as an indication of the value of our company or our common stock.If you do not act on a timely basis and follow subscription instructions, your exercise of Subscription Rights may be rejected.Holders of Subscription Rights who desire to purchase shares of our Preferred Stock and Warrants in this offering must act on a timely basis to ensure that all required forms and payments are actually received by the Subscription Agent prior to 5:00 p.m., New York City time, on the expiration date, unless extended.